Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An update from Recce Pharmaceuticals Ltd. ( (AU:RCE) ) is now available.
Recce Pharmaceuticals Ltd has announced an update to its previous announcement regarding the proposed issue of securities. The company has revised the dates for the offer closing, trading commencement on a deferred settlement basis, and the issue date, among others. This update is crucial for stakeholders as it outlines the timeline for the securities offering, which could impact the company’s financial strategy and market positioning.
More about Recce Pharmaceuticals Ltd.
Recce Pharmaceuticals Ltd is a company operating in the pharmaceutical industry, focusing on the development and commercialization of novel synthetic anti-infectives. The company is dedicated to addressing the urgent global health challenge of antibiotic-resistant superbugs.
YTD Price Performance: -40.62%
Average Trading Volume: 218,413
Technical Sentiment Signal: Buy
Current Market Cap: A$77.1M
See more data about RCE stock on TipRanks’ Stock Analysis page.